Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04905264 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Severe Acquired Brain Injuries: Prognostic Factors and Quality of Care

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site details revised at 2 of 27 sites
    • Publications: details revised at 1 of 1 entry
    • Eligibility criteria expanded, about 2 words
    • Study description expanded, about 3 words
  2. Primary and study completion dates: Jun 30, 2025 to Jun 2027v8
  3. Study sites: 26 to 27v7
  4. Study sites: 21 to 26v6
  5. Re-verified, no change to tracked fieldsv5
Show 3 earlier versionsHide 3 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 3 to 21
    • Start date changed from estimate of Jan 1, 2022 to Jan 3, 2022
    v4
  2. Start date: Jul 1, 2021 to Jan 1, 2022v3
  3. Eligibility criteria shortened, about 11 wordsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main purpose of this project is to identify the medium-term prognostic factors for patients with Severe Acquired Brain Injuries and evaluate their impact. The secondary aim is to create a system of continuous assessment of the quality of care for each rehabilitation unit.
Trial Details
NCT Number NCT04905264
Lead Sponsor Mario Negri Institute for Pharmacological Research
Conditions
(from sponsor)		 Brain Injuries, Acute
Related terms Brain Injuries
Enrollment 2,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov